Hôpital La Pitié-Salpêtrière
Paris, France
NCT Number: NCT03878251
Objective quantitative primary endpoints are lacking in Clinical trials in intellectual disability. We propose to develop quantitative interactive attention evaluation criteria in patients with intellectual disability by using games on touchscreen and or eye tracking.
Looking for future studies?
Notify Me6 year and older
All sexes
Interventional
Not applicable
Paris, France
The aim of the study is to develop and validate quantitative interactive attention evaluation criteria by using games on touchscreen and or eye tracking in patients with intellectual disability. Tests will have to be suitable whatever severity and etiology of intellectual disability. Tests have to evaluate attention and concentration troubles in intellectual disability.Once validated, tests could be used as outcome measures in clinical trials and as cognitive reeducation tools in intellectual disability.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Quantitative interactive attention evaluation tests by using games on touchscreen and or eye tracking (oculometer)
Time frame: up to 3 months
Test performed 1 time during a visit (1 day) can be repeated (for a maximum of 15 patients) within 3 months if an adaptation of the interactive tool is necessary
Time frame: up to 3 months
Time frame: up to 3 months
Time frame: up to 3 months
Time frame: up to 3 months
Time frame: up to 3 months
Time frame: up to 3 months
Time frame: up to 3 months
Time frame: up to 3 months
Assistance Publique - Hôpitaux de Paris
Other
Development and Validation of Quantitative Attention Evaluation Criteria in Patients With Intellectual Disability
Acronym: EVALDI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01031407
Adult, Asperger Syndrome
Bethesda, Maryland, United States
View Trial DetailsNCT07729163
Behavior, Intellectual Disability
Mersin, Turkey (Türkiye)
View Trial DetailsNCT07220837
Behavior, Developmental Disabilities
The Bronx, New York, United States
View Trial DetailsNCT06592404
Abnormalities, Multiple, Autism Spectrum Disorder
Sittard, Limburg, Netherlands
View Trial Details